Invitrogen Introduces Customizable PlateSelect™ RNAi Duplexes

Invitrogen Corporation has announced the launch of the company’s PlateSelect™ RNAi duplexes, which offers customers the ability to customize 96 well-plates with Invitrogen’s chemically modified Stealth™ or standard BLOCK-iT™ RNAi duplexes.

Customers develop their customized plates using a Web interface, and they can order anywhere from one to 96 different duplexes in a single plate.

The RNAi duplexes are synthesized on demand to take advantage of the most up-to-date bioinformatics and are provided at 1 nmol/well in the well orientation that a customer chooses.

In addition, PlateSelect RNAi duplexes arrive in ready to transfect format and are synthesized based on algorithms designed to reduce the chances of off-target effects.